These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 15956629)
41. Intellectual property and biotechnology: the U.S. internal experience--Part I. Brody B Kennedy Inst Ethics J; 2006 Mar; 16(1):1-37. PubMed ID: 16770885 [TBL] [Abstract][Full Text] [Related]
42. Much ado about gene patents: the role of foreseeability. Gulliford MJ Seton Hall Law Rev; 2004; 34(2):711-45. PubMed ID: 15115032 [No Abstract] [Full Text] [Related]
45. Innovators working hard to avoid patent exclusions in the US. Tombling A Drug Discov Today; 2013 Dec; 18(23-24):1131-2. PubMed ID: 24120891 [No Abstract] [Full Text] [Related]
47. Pharmaceutical patent life-cycle management after KSR v. Teleflex. Furrow ME Food Drug Law J; 2008; 63(1):275-320. PubMed ID: 18561462 [No Abstract] [Full Text] [Related]
49. Ordering life: law and the normalization of biotechnology. Jasanoff S Not Polit; 2001; 17(62):34-50. PubMed ID: 15468485 [No Abstract] [Full Text] [Related]
50. Bungled law threatens Italian tech transfer. Meldolesi A Nat Biotechnol; 2001 Nov; 19(11):996-7. PubMed ID: 11689829 [No Abstract] [Full Text] [Related]
54. Should the patent system for new medicines be abolished? DiMasi JA; Grabowski HG Clin Pharmacol Ther; 2007 Nov; 82(5):488-90. PubMed ID: 17952100 [No Abstract] [Full Text] [Related]
55. Data-sharing and data-withholding in genetics and the life sciences: results of a national survey of technology transfer officers. Campbell EG; Bendavid E J Health Care Law Policy; 2003; 6(2):241-55. PubMed ID: 15017960 [No Abstract] [Full Text] [Related]
56. US policy may encourage counterfeit drugs. Bouchie A Nat Biotechnol; 2003 Feb; 21(2):121. PubMed ID: 12560826 [No Abstract] [Full Text] [Related]
57. Biotech reels over patent ruling. Check-Hayden E Nature; 2014 Jul; 511(7508):138. PubMed ID: 25008505 [No Abstract] [Full Text] [Related]
59. The application of the patent laws to the drug approval process. Coggio BD; Cerrito FD Food Drug Law J; 1997; 52(4):345-55. PubMed ID: 10346669 [No Abstract] [Full Text] [Related]
60. Safe harbors in Europe: an update on the research and Bolar exemptions to patent infringement. Kupecz A; Roox K; Dekoninck C; Schertenleib D; Stief M; Sanna F; Orsingher M; Miralles S; Molina E; Crosse T; Gilbert M; James W Nat Biotechnol; 2015 Jul; 33(7):710-5. PubMed ID: 26154008 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]